Evidence map›Paper›PMID 29478779›Full record

ArticleAmerican journal of human genetics2018

Loss of Function of the Nuclear Receptor NR2F2, Encoding COUP-TF2, Causes Testis Development and Cardiac Defects in 46,XX Children.

Anu Bashamboo, Caroline Eozenou, Anne Jorgensen, Joelle Bignon-Topalovic, Jean-Pierre Siffroi, Capucine Hyon, Attila Tar, Péter Nagy, Janos Sólyom, Zita Halász and 8 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Differences of sex development.Nature reviews. Disease primers · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Anu BashambooHuman Developmental Genetics, Institut Pasteur, Paris 75724, France.
Caroline EozenouHuman Developmental Genetics, Institut Pasteur, Paris 75724, France.
Anne JorgensenDepartment of Growth and Reproduction, Rigshospitalet, Copenhagen 2100, Denmark.
Joelle Bignon-TopalovicHuman Developmental Genetics, Institut Pasteur, Paris 75724, France.
Jean-Pierre SiffroiDepartment of Medical Genetics, Hospital Trousseau-APHP, Paris 75012, France.
Capucine HyonDepartment of Medical Genetics, Hospital Trousseau-APHP, Paris 75012, France.
Attila TarHeim Pál Children's Hospital, Budapest 1089, Hungary.
Péter NagyFirst Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Janos SólyomDepartment of Pediatrics, Semmelweis University, Budapest 1085, Hungary.
Zita HalászDepartment of Pediatrics, Semmelweis University, Budapest 1085, Hungary.
Annnabel Paye-JaouenPediatric and Visceral Surgery and Urology, Hopital Robert Debre, Paris 75019, France.
Sophie LambertEndocrinologie et Diabetologie Pediatrique, Hopital Robert Debre, Paris 75019, France.
David Rodriguez-BuriticaDivision of Genetics, Department of Pediatrics, McGovern Medical School, University of Texas, Houston, TX 77030, USA.
Rita BertalanHuman Developmental Genetics, Institut Pasteur, Paris 75724, France.
Laetitia MartinerieEndocrinologie et Diabetologie Pediatrique, Hopital Robert Debre, Paris 75019, France.
Ewa Rajpert-De MeytsDepartment of Growth and Reproduction, Rigshospitalet, Copenhagen 2100, Denmark.
John C AchermannUCL GOSH Institute of Child Health, London WC1N 1EH, UK.
Ken McElreaveyHuman Developmental Genetics, Institut Pasteur, Paris 75724, France. Electronic address: kenmce@pasteur.fr.
Institut Pasteur · FRHôpital Robert-Debré · FRSemmelweis University · HURigshospitalet · DKSorbonne Université · FRHeim Pál Országos Gyermekgyógyászati Intézet · HUUniversity College London · GB

Funding

Wellcome TrustWellcome Trust 098513/Z/12/ZWellcome Trust 209328/Z/17/Z
6 · The paper itself

Abstract

Emerging evidence from murine studies suggests that mammalian sex determination is the outcome of an imbalance between mutually antagonistic male and female regulatory networks that canalize development down one pathway while actively repressing the other. However, in contrast to testis formation, the gene regulatory pathways governing mammalian ovary development have remained elusive. We performed exome or Sanger sequencing on 79 46,XX SRY-negative individuals with either unexplained virilization or with testicular/ovotesticular disorders/differences of sex development (TDSD/OTDSD). We identified heterozygous frameshift mutations in NR2F2, encoding COUP-TF2, in three children. One carried a c.103_109delGGCGCCC (p.Gly35Argfs

Indexed as

46, XX Disorders of Sex DevelopmentAmino Acid SequenceBase SequenceChildCOUP Transcription Factor IIFemaleForkhead Box Protein L2Frameshift MutationHeterozygoteHumansLoss of Function MutationMaleOvaryPhenotypeTestisCOUP Transcription Factor IIForkhead Box Protein L2NR2F2 protein, humanCOUP-TF2new syndromeNR2F2nuclear receptorsex determinationtesticular DSD

Identifiers

PMID29478779
PMCPMC5985285
OpenAlexW2788119281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.